News & Updates
Filter by Specialty:

Cutting first-day dexamethasone dose not recommended for breast cancer patients on anthracycline
11 Dec 2021
In breast cancer patients treated with anthracycline-containing regimens, reducing the first-day dose of dexamethasone does not yield significant gastrointestinal benefit and is not recommended for nausea management, a recent study has found.
Cutting first-day dexamethasone dose not recommended for breast cancer patients on anthracycline
11 Dec 2021
Sildenafil efficacy, safety sustained regardless of delivery method
11 Dec 2021
byAudrey Abella
Sildenafil orally disintegrating strips (ODS) are just as effective and safe as the conventional tablet formulation for the treatment of erectile dysfunction (ED), a Thai study suggests.